Nrl Pharma, Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 66.7

CIPO Patents = 3

EPO Patents = 4

Forward Citations = 24

Loading Chart...

10 inventors (with patents filed for the assignee):

Kunio Ando (3 out of 11 patents)

Atsushi Sato (3 out of 23 patents)

Shinji Kagaya (2 out of 4 patents)

4. Takeshi Kitahara (2 out of 9 patents)

5. Hidenori Watanabe (2 out of 2 patents)

6. Takashi Takeuchi (1 out of 2 patents)

7. Yasuhiro Nojima (1 out of 1 patent)

8. Etsumori Harada (1 out of 1 patent)

9. Kenichiro Hayashida (1 out of 1 patent)

10. Hirohiko Shimizu (1 out of 1 patent)

11. Mako Kamiya (13 patents)

12. Yasuteru Urano (35 patents)

13. Koushu Okubo (0 patent)

14. Junichi Hirahashi (0 patent)

15. Atsushi Sato (0 patent)

6 patents: Sort by Forward Citations

1. 10562959 - Lactoferrin fusion protein and method for preparation thereof (2020-02-18),

2. 9809641 - Lactoferrin fusion protein and method for preparation thereof (2017-11-07),

3. 8673839 - Lactoferrin complex and method of producing the same (2014-03-18),

4. 8399414 - Analgesics (2013-03-19),

5. 7629471 - Transcriptional factor, process for producing the same and use thereof (2009-12-08),

6. 7432306 - Method for preparing novel transcription factors and use (2008-10-07),

Company Overview

Nrl Pharma, Inc. is a leading pharmaceutical company specializing in the development and commercialization of innovative medicines for various therapeutic areas. With a focus on research and development, we strive to bring cutting-edge treatments to patients worldwide. Our dedicated team of experts is committed to improving healthcare outcomes and enhancing the quality of life for individuals in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#217 in Kanagawa

#5,990 in Japan

Kanagawa, Japan

Nrl Pharma, Inc.

Forward Citations = 24

10 inventors:

Kunio Ando (3 out of 11 patents)

Atsushi Sato (3 out of 23 patents)

Shinji Kagaya (2 out of 4 patents)

4. Takeshi Kitahara (2 out of 9 patents)

5. Hidenori Watanabe (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nrl Pharma, Inc.. Retrieved from https://idiyas.com/company/nrl-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]